Abstract:
A fetal pulse oximeter sensor in which a sensor head (10) is held against the fetus (14) by the action of a securing means (20, 24) which is remote from the sensor head. The securing means is sufficiently remote so that light detected by the light detector (48) in the sensor head does not scatter through tissue which may be deformed by the securing mechanism. The securing mechanism could deform the tissue by applying pressure, to exanguinate the tissue, or could attach to the tissue by vacuum, penetration, or glue, etc.
Abstract:
An improved infant/neonatal pulse oximeter sensor substrate which is preferably conforming to the shape of the infant or neonate's foot. In one embodiment, the pad (10) conforms to the heel of the infant, with the emitter (14) and detector (20) preferably being mounted in the region of the calcaneus bone (26). The heel pad can be held in place with a stretchable sock (52). In an alternate embodiment, the conformable pad is a sock (52) with recesses or pockets (54, 56) cut in it for holding the emitter (14) and detector (20).
Abstract:
Method and apparatus for non-invasively determining glucose level in fluid of subject, typically blood glucose level. A particular device (10) is mounted on the skin of the patient for a fixed period of time. The device (10) is mounted on the skin such that a substrate such as paper (12) or gel or an aqueous glucose solution carried by the device are in contact with the patient's skin. Water and/or glucose migrates between the substrate (12) or the aqueous glucose solution of the device. The degree of migration of the substance in question is monitored, for example the amount of glucose remaining in an aqueous solution of the device is measured at the end of the fixed period. This can be done by a conventional or other spectrophotometric method, for example. The glucose level is determined based on the degree of migration of the migrating substance. That is, the degree of migration is correlated with previously determined fluid glucose levels based on directly measured fluid glucose levels. In another approach, impedance of skin tissue is measured and the measurement is used with impedance measurements previously correlated with directly determined glucose levels to determine the glucose level from the newly measured impedance. It is thus possible to routinely non-invasively determine fluid glucose levels.
Abstract:
A blood pressure can be obtained by supplying an external pressure to a portion of an artery. The external pressure is preferably between the systolic and diastolic pressure. An event which occurs at least once a cycle can then be identified. This event can be, for example, a peak in the arterial compliance that occurs at a transmural pressure approximately equal to zero. A pair of signals, one that is an arterial volume-indicating signal, and one that is an arterial pressure-indicating signal can be used to identify this event. Alternately, a small signal high-frequency exciter component can be placed upon the pressure or volume of the artery and detected to determine the time that the transmural pressure is equal to zero.
Abstract:
The present invention involves the use of fluorescence spectroscopy in the diagnosis of cervical cancer and precancer. Using multiple illumination wavelengths, it is possible to (i) differentiate normal or inflamed tissue from squamous intraepithelial lesions (SILs) and (ii) to differentiate high grade SILs from non-high grade SILs. The detection may be performed in vitro or in vivo. Multivariate statistical analysis was employed to reduce the number of fluorescence excitation-emission wavelength pairs needed to re-develop algorithms that demonstrate a minimum decrease in classification accuracy. Fluorescence at excitation-emission wavelength pairs was used to redevelop and test screening and diagnostic algorithms that have a similar classification accuracy to those that employ fluorescence emission spectra at three excitation wavelengths. Both the full-parameter and reduced-parameter screening algorithms discriminate between SILs and non-SILs with a similar specificity and a substantially improved sensitivity relative to Pap smear screening and differentiate high grade SILs from non-high grade SILs.
Abstract:
A guidewire (10) comprises a core wire (12) having a coil tip at its distal end. The coil tip includes a helically wound filament (28) having adjacent turns spaced apart by a preselected distance. The guidewire (10) is coated with a polymeric material (54), typically a hydrophilic polysaccharide, such as hyaluronic acid or chondroitin sulphate. By properly selecting the spacing between adjacent turns of the coil tip (16), the hydrophilic coating (54) will adhere to the coil tip (16) in a manner which does not penetrate the coil and which does not significantly interfere with flexibility and bend ability of the coil tip.
Abstract:
The overall invention categorizes patients with suspected acute myocardial infarction (AMI) with regard to a) AMI/non-AMI; b) infarct size (e.g. Major/Minor); c) time since onset of infarction; and d) non-AMI with/without minor myocardial damage (MMD). Generally, the above categorization is based on frequent timed blood sampling and measurement of selected biochemical markers of AMI with different rates of appearance in circulating blood. The computations are performed by using specially designed artificial neural networks. According to a first main aspect of the invention, early, i.e. generally within 3 hours from admission of the patient, detection/exclusion of acute myocardial infarction is provided. Furthermore, early prediction of the infarct size and early estimation of the time from onset are also provided.
Abstract:
The present invention is directed to a pulse oximeter sensor (24) and an attached flexible carrier (28) for measuring the oxygen saturation of a patient's blood. The carrier includes a compressible material (56) such as foam, for contacting the patient's skin and the sensor that applies a substantially uniform pressure to the skin.
Abstract:
The invention concerns a method of detecting parasitic signals caused by movements of the patient or his environment during pulsoxymetric measurement of the saturation with oxygen of the arterial blood. According to this method, the intensity of the light emerging from the object to be measured is measured using two photodiodes (7, 8). The signals (S1, S2) generated at these photodiodes (7, 8) are normalized to the same level of their DC portions. Finally, the differences ( DELTA Sn) of these normalized signals (S1n, S2n) are formed in order to detect parasitic signals caused by movement.
Abstract:
An analytical specimen cup system (10) includes a lid (14) comprising outer and inner partitions (42, 40) for defining a test space (44) having a chemical test strip (30) mounted therein. The inner partition defines a raised test-strip shelf (61) on which the chemical test strip is mounted, a sump (64) with a floor (62) positioned substantially below the raised shelf, and an opening-defining member (48) for defining an opening (50) to allow test fluid to be transferred from an analytical specimen cup (12) to the test space. A mouth (60) of the opening is vertically positioned intermediate the raised test-strip shelf and the sump floor. In one embodiment the analytical specimen cup has a membrane (24) covering its mouth (18) and is sterilized separately from the lid. The inner partition includes a specimen-release device (52) for uncovering the opening of the opening-defining member as well as for piercing the membrane. A peel-off-label color chart (36) can be marked to indicate the chemical test strip's color and placed on a patient's chart.